Discover
INMB
INmune Bio Inc.
1.68
2 x 1.24
2 x 2.11
bid
ask
+
0.05
3.07%
2 @ 05:25 AM
1.67 -0.01 (0.62%)
| Ytd | 7.69% | |
| 1y | -19.62% |
1.62
day range
1.73
1.09
52 week range
3.24
| Open | 1.62 | Prev Close | 1.63 | Low | 1.62 | High | 1.73 | Mkt Cap | 44.66M |
| Vol | 748.52K | Avg Vol | 627.18K | EPS | -1.63 | P/E | N/A | Forward P/E | -2.23 |
| Beta | 1.85 | Short Ratio | 18.08 | Inst. Own | 24.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 1.41 | 200-d Avg | 1.56 | 1yr Est | 19.83 |
| Income Statement | |||
| Operating Expenses | 5.81M | ||
| Research and Development Expense | 3.64M | ||
| Selling, General and Administrative Expense | 2.17M | ||
| Operating Income | -5.81M | ||
| Net Income | -5.41M | ||
| Net Income Common Stock | -5.41M | ||
| Net Income Common Stock (USD) | -5.41M | ||
| Consolidated Income | -5.41M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -5.41M | ||
| Earning Before Interest & Taxes (USD) | -5.41M | ||
| Weighted Average Shares | 26.59M | ||
| Weighted Average Shares Diluted | 26.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 21.36M | ||
| Cash and Equivalents (USD) | 21.36M | ||
| Current Assets | 22.82M | ||
| Property, Plant & Equipment Net | 2.31M | ||
| Total Assets | 25.82M | ||
| Debt Current | 704.00K | ||
| Total Debt | 1.51M | ||
| Current Liabilities | 5.39M | ||
| Debt Non-Current | 806.00K | ||
| Total Liabilities | 6.19M | ||
| Accumulated Retained Earnings (Deficit) | -214.44M | ||
| Accumulated Other Comprehensive Income | -727.00K | ||
| Shareholders Equity | 19.62M | ||
| Shareholders Equity (USD) | 19.62M | ||
| Assets Non-Current | 3.00M | ||
| Total Debt (USD) | 1.51M | ||
| Liabilities Non-Current | 806.00K | ||
| Trade and Non-Trade Payables | 4.68M | ||
| Tax Assets | 770.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 52.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.39M | ||
| Net Cash Flow from Operations | -3.40M | ||
| Effect of Exchange Rate Changes on Cash | 10.00K | ||
| Share Based Compensation | 1.50M | ||